These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27974715)

  • 1. HIV Drug Resistance and Phylogeny Profile in Naïve and Antiretroviral-Experienced Patients in Tehran, Iran.
    Farrokhi M; Moallemi S; Baesi K; Ahsani-Nasab S; Gholami M; Sadeghi L; Mohraz M
    Intervirology; 2016; 59(3):131-136. PubMed ID: 27974715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.
    Memarnejadian A; Menbari S; Mansouri SA; Sadeghi L; Vahabpour R; Aghasadeghi MR; Mostafavi E; Abdi M
    PLoS One; 2015; 10(5):e0126955. PubMed ID: 25962088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 genetic diversity and transmitted drug resistance frequency among Iranian treatment-naive, sexually infected individuals.
    Vahabpour R; Bokharaei-Salim F; Kalantari S; Garshasbi S; Monavari SH; Esghaei M; Memarnejadian A; Fakhim A; Keyvani H
    Arch Virol; 2017 Jun; 162(6):1477-1485. PubMed ID: 28181034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Frequency of HIV-1 Infection in Iranian Children and Determination of the Transmitted Drug Resistance in Treatment-Naïve Children.
    Jarchi M; Bokharaei-Salim F; Esghaei M; Kiani SJ; Jahanbakhsh F; Monavari SH; Ataei-Pirkooh A; Marjani A; Keyvani H
    Curr HIV Res; 2019; 17(6):397-407. PubMed ID: 31702525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of drug resistance mutations in the human immunodeficiency virus reverse transcriptase gene in patients who are non-responsive, responsive and naive to antiretroviral therapy.
    Misbah M; Roy G; Shahid M; Nag N; Kumar S; Husain M
    Arch Virol; 2016 May; 161(5):1101-13. PubMed ID: 26801790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
    Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
    J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Acquired HIV Drug Resistance among People Living with HIV Who Have Taken Antiretroviral Therapy for 9-15 Months in 14 Triangular Clinics in Iran, 2015-2016.
    Mohraz M; Tayeri K; Namdari Tabar H; Bayat Jozani Z; Sadeghi L; SeyedAlinaghi S; Esmaeilzadeh A; Adl Tabatabai R; Sajjadipour M; Gholami M; Bayanolhagh S
    Intervirology; 2018; 61(6):292-300. PubMed ID: 30861512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011.
    Jahanbakhsh F; Hattori J; Matsuda M; Ibe S; Monavari SH; Memarnejadian A; Aghasadeghi MR; Mostafavi E; Mohraz M; Jabbari H; Kamali K; Keyvani H; Azadmanesh K; Sugiura W
    PLoS One; 2013; 8(4):e61864. PubMed ID: 23626742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey.
    Steegen K; Carmona S; Bronze M; Papathanasopoulos MA; van Zyl G; Goedhals D; MacLeod W; Sanne I; Stevens WS
    PLoS One; 2016; 11(12):e0166305. PubMed ID: 27907009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1.
    Handema R; Terunuma H; Kasolo F; Kasai H; Sichone M; Yamashita A; Deng X; Mulundu G; Ichiyama K; Munkanta M; Yokota T; Wakasugi N; Tezuka F; Yamamoto N; Ito M
    AIDS Res Hum Retroviruses; 2003 Feb; 19(2):151-60. PubMed ID: 12643279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral drug resistance among antiretroviral-naïve and treatment experienced patients infected with HIV in Iran.
    Baesi K; Ravanshad M; Ghanbarisafari M; Saberfar E; Seyedalinaghi S; Volk JE
    J Med Virol; 2014 Jul; 86(7):1093-8. PubMed ID: 24740443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of transmitted genetic drug resistance in a cohort of HIV infected naïve patients entering antiretroviral treatment programs at two sites in northern South Africa.
    Nwobegahay J; Selabe G; Ndjeka NO; Manhaeve C; Bessong PO
    J Med Virol; 2012 Dec; 84(12):1839-43. PubMed ID: 23080485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The First Characterization of HIV-1 Subtypes and Drug Resistance Mutations among Antiretrovirally Treated Patients in Kermanshah, Iran.
    Golmohammadi R; Baesi K; Moradi A; Farrokhi M; McFarland W; Parsamajd S
    Intervirology; 2017; 60(1-2):33-37. PubMed ID: 28795954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.
    Aghokeng AF; Kouanfack C; Laurent C; Ebong E; Atem-Tambe A; Butel C; Montavon C; Mpoudi-Ngole E; Delaporte E; Peeters M
    AIDS; 2011 Nov; 25(17):2183-8. PubMed ID: 21860346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of HIV-1 transmitted drug resistance in recently infected, treatment-naïve persons in the Southwest of Iran, 2014-2015.
    Ghafari S; Memarnejadian A; Samarbaf-Zadeh A; Mostafavi E; Makvandi M; Salmanzadeh S; Ghadiri A; Jordan MR; Mousavi E; Jahanbakhsh F; Azadmanesh K
    Arch Virol; 2017 Sep; 162(9):2737-2745. PubMed ID: 28589513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
    Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
    Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV type 1 subtype diversity and drug resistance among HIV type 1-infected Kenyan patients initiating antiretroviral therapy.
    Lihana RW; Khamadi SA; Lubano K; Lwembe R; Kiptoo MK; Lagat N; Kinyua JG; Okoth FA; Songok EM; Makokha EP; Ichimura H
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1211-7. PubMed ID: 19954302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phylogenetic analysis of HIV-1 subtypes and drug resistance profile among treatment-naïve people in Kuwait.
    Chehadeh W; Albaksami O; Altawalah H; Ahmad S; Madi N; John SE; Abraham PS; Al-Nakib W
    J Med Virol; 2015 Sep; 87(9):1521-6. PubMed ID: 25976289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.